Pathos AI
Business Services · Illinois, United States · 51-200 Employees
View Company Info for Free
Overview
Headquarters
600 W Chicago Ave Ste 150, Chicago, Illi...Website
www.pathos.comRevenue
$14.7 MillionIndustry
ZI Rank: 1
Signal Type
Dec
Jan
Feb
Mar
Apr
May
ZI Rank
2
3
1
3
1
1
About Pathos AI
Pathos is an AI-enabled biotechnology company focused on re-engineering drug development, leveraging the power of technology to bring precision medicine to patients through partnerships with pharmaceutical companies.Explore more
Pathos AI Org Chart
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Is Pathos AI your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Earning: See what the market has to say on Pathos AI recently announced quarterly report
Pathos AI, which may be a good buyer, showed buying intent in Masked Content Topic
Funding: Get notified immidiatlly once Pathos AI has new funding data
Website visits: Recent activity has been detected on your website
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Click to see if Pathos AI had a recent Job posting/layoffs
Product Launch: Get notified when Pathos AI launches new products
Check if Pathos AI has recently received funding, and reach out quickly before it becomes old news!
Congratulate Masked Content for being promoted to Masked Content at Pathos AI
Check out if Pathos AI is spiking on competitors!
Recommended Actions
Reach out to Masked Content who joined Pathos AI as Masked Content
Find 2 more new buyers
Compare Similar Companies to Pathos AI
Compare insights from companies similar to Pathos AI, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.
Revenue
Number of Employees
Type
Funding
Founded In
Company Profile Activity
Activity Insights
Pathos AI is experiencing very low activity levels compared to other companies in the Business Services sector.
What does this means?
Pathos AI is drawing exceptional interest within the Business Services industry, suggesting notable developments or strong market momentum, learn more about Pathos AI.
Pathos AI financials insights
Gather financial insights about Pathos AI, including details on funding rounds, investors, total funding, and acquisitions, to gain a comprehensive understanding of their financial strategy.
2024
Series C
$62M
2025
Series D
$365M
Pathos AI Tech Stack
A closer look at the technologies used by Pathos AI
See more technologies
Most Recent Scoops
Open Position
Open Position
Open Position
Partnership
Project
Laboratory Operations, Medical Research, Clinical Operations
Hiring Plans
Hiring Plans
Pathos AI News & Media
Pathos AI collects $365M to fuel 'bulletproof' oncology trials and in-license more cancer drugs
Pathos AI, seeking to upend cancer drug development with artificial intelligence and large multimodal models, has raised the third-largest private funding round in biotech so far this year.Pathos AI Secures $365 Million in Series D Financing to Advance Oncology Drug Development Through AI
NEW YORK, May 15, 2025 (GLOBE NEWSWIRE) -- Pathos AI, a leading AI-driven biotech company applying cutting-edge artificial intelligence to drug development, today announced its $365 million Series D financing, bringing its post-money valuation to approximately $1.6 billion.Pathos AI Appoints Iker Huerga as Chief Executive Officer to Lead the Next Era of AI-Enabled Drug Development
NEW YORK, May 08, 2025 (GLOBE NEWSWIRE) -- Pathos AI, a leading AI-enabled biotech company focused on transforming drug development in oncology, today announced the appointment of Iker Huerga as Chief Executive Officer and Board Member.
Read more news
Top Business Services Companies
Top companies in Australia by revenue
Frequently Asked Questions Regarding Pathos AI
Sign Up For FreeTo access detailed company insights
Pathos is an AI-enabled biotechnology company focused on re-engineering drug development, leveraging the power of technology to bring precision medicine to patients through partnerships with pharmaceutical companies.... Read More
